A glance at what’s happening in the world of technology.
Big data balances glaucoma risk with COVID
Research has shown that big data can assist with triaging glaucoma patients during the COVID-19 outbreak.
Scientists at the University of Michigan developed a risk stratification tool that weighed the ocular risks of delay to treatment with the threat to health of exposure to COVID-19 in clinical environments – a common reason for postponing glaucoma treatment.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Glaucoma is the second leading cause of irreversible sight loss in the UK and affects over one million people, which is predicted to rise by 100,000 cases to 1.145 million people by 2030*.
The College of Optometrists has published its first issue of Ophthalmic and Physiological Optics (OPO), its flagship international and interdisciplinary research journal for contemporary vision science and optometry, with its new publishing partner Springer Nature this month.
